Please assess the completion status of the following clinical trial:

Trial Title: OASIS-IPF (Idiopathic Pulmonary Fibrosis) Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Female and male patients ≥ 40 years of age~* Patients diagnosed with Idiopathic Pulmonary Fibrosis (IPF) according to last ATS/ERS/JRS/ALAT IPF guideline for diagnosis and management consensus~* Written informed consent prior to participation~Exclusion Criteria:~* Inability for the patient to understand or complete the written Inform Consent or patients questionnaires or to understand Spanish~* Current participation in any clinical trial~* Patients for whom further follow-up is not possible at the enrolling site

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Idiopathic Pulmonary Fibrosis patients (Type: None): all IPF patients

Based on this trial design, predict the completion outcome and termination type (if applicable).